Top selling health author documents how a simple spice from India has for more than 3500 years been inhibiting the actual development and proliferation of all cancer. His "Christian Wilde Stem Cell And Turmeric Research Report" also shares how stem cells are currently being used to treat more than 89 diseases including heart failure, MS, Diabetes, Spinal Injury and Parkinson's abigon.com
Studio City, CA (PRWEB) November 17, 2009 -- The American Cancer Society has publicly announced that cancer will in 2010, surpass heart disease as the number one killer of people worldwide. Is there something of value families can learn from the country of India where the incidence for all cancers are among the lowest on the planet?
Author/researcher "Christian Wilde's Wilde Stem Cell and Turmeric Research Report" continues to share not only the current progress in stem cell research for more than 80 diseases including heart failure, MS, diabetes, spinal injury, Parkinson's but also the documented scientific evidence of how a simple yellow spice from India has been inhibiting the actual development and proliferation of cancer for more than 3500 years. (www.abigon.com)
There is a remarkable difference in all cancer rates between the populations of the U.S. and India. An earlier study featured in the news reports has documented that of one million America women, 660 will statistically develop breast cancer resulting in 160 deaths. However, when the study also compared cases of breast cancer among one million women in India, it was determined that only 79 will be diagnosed with a subsequent number of 41 deaths. For men, prostate cancer kills 130 out of one million in the U.S. while India reports only 9 prostate cancer deaths. Pancreatic cancer claims 103 in the U.S, compared to only 8 deaths in India. The author's reports explain the science of how turmeric, as shown in studies is proving to be helpful in preventing various types of cancers.
The medical profession informs us we are living longer as a population, but with that longevity will come a dramatic increase in cases of dementia and Alzheimer's disease affecting millions of families. By comparison India, because of the consumption of turmeric, continues to enjoy the lowest incidence of dementia and Alzheimer's disease in the world. Turmeric inhibits the formation of amyloid plaque buildup, believed to be a contributing cause of dementia. The research report on Alzheimer's discusses how stem cells, pharmaceutical medications and natural aids are showing promise in treating or delaying this memory robbing disease. (abigon.com)
Is there scientific evidence explaining how turmeric is able to do what researchers say it does? Is there documented peer support for the claims being made that turmeric not only inhibits the development of cancer but also it's proliferation and metastasizing once it is diagnosed? In order to answer many questions readers have asked regarding the claims about turmeric's extraordinary abilities, the author sought the advice of the world's leading authority on turmeric/curcumin research. He is Ph.D, Bhrat Aggarwal, Professor of Cancer Research and Professor of Cancer Medicine (Biochemistry) and Chief, Cytokine Research Laboratory, Department of Experimental Therapeutics, University of Texas/MD Anderson Cancer Clinic.
The "Christian Wilde Stem Cell and Turmeric and Research Report" explains how through a process known as apoptosis (cell death) turmeric is able to actually instruct the cancer cell to self-destruct. This process of programmed cell death (PCD) is the result physicians hope to attain in treating patients with chemotherapy and radiation. These treatments kill cancer cells but unfortunately they cannot distinguish the cancer cell from the healthy cell and both cells are destroyed in the process. According to Professor Aggarwal, turmeric has the ability to target and kill the cancer cell while leaving the healthy cell intact. Dr. Sharon McKenna and her research team published their findings in a most recent issue of the British Journal Cancer, further confirming the phenomena of cell death. Dr. McKenna found that curcumin began to kill cancer cells within 24 hours. The cells also began to digest themselves, after the curcumin triggered lethal [cell death signals. Turmeric can reduce some of the toxicity created by chemotherapy as well as improving the result of chemotherapy and radiation when used in combination with certain drugs. There are some remarkable recent findings from Israel in treating pancreatic disease.
Scientists understand how turmeric is able to function as an anti-microbial, anti-infection, anti-inflammatory, anti-oxidant, immune stimulating, anti-cancer and a natural COX-2 inhibitor of inflammation for arthritis and other inflammatory diseases. Yes, as amazing as it seems, turmeric/curcumin possesses the ability to perform as an agent in all of the above. No wonder all the excitement-but why has this realization taken this long? Does the reason lie in part in the fact that the pharmaceutical industry has been trying for decades to have the FDA change turmeric's classification to a drug instead of a spice so they might synthesize curcumin's properties into an expensive drug?
Turmeric for heart disease? Studies have shown turmeric's dual ability to help lower LDL cholesterol and to lower inflammation (a major killer in heart disease). One issue of the report describes how studies have shown turmeric actually reduces the size of the enlarged heart which is a critical result of heart failure. Christian Wilde along with authoring the Stem Cell and Turmeric Research Report has also written two groundbreaking books on heart disease "Hidden Causes of Heart Attack and Stroke" (inflammation, cardiology's new frontier) and "Miracle Stem Cell Heart Repair."
One drawback, turmeric is not well absorbed by the body as 66% is lost in the feces and urine. There is, however, one form of turmeric that produces five times the absorption rate of regular turmeric. Both forms of turmeric are available at discount at (www.abigon.com)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3177234.htm.
Copyright©2009 Vocus, Inc.
All rights reserved